438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models
| Title: | 438 Synergy between SEA-CD40 and chemotherapeutics drives curative antitumor activity in preclinical models |
|---|---|
| Authors: | Michael Schmitt, Weiping Zeng, Celine Jacquemont, Haley Neff-LaFord, Sahar Ansari |
| Source: | Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020) |
| Publisher Information: | BMJ Publishing Group, 2020. |
| Publication Year: | 2020 |
| Collection: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
| Subject Terms: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2051-1426 |
| Relation: | https://doaj.org/toc/2051-1426 |
| DOI: | 10.1136/jitc-2020-SITC2020.0438 |
| Access URL: | https://doaj.org/article/da855c2eba5046209c813624db008aad |
| Accession Number: | edsdoj.855c2eba5046209c813624db008aad |
| Database: | Directory of Open Access Journals |
| ISSN: | 20511426 |
|---|---|
| DOI: | 10.1136/jitc-2020-SITC2020.0438 |
| Published in: | Journal for ImmunoTherapy of Cancer |
| Language: | English |